Hp1bp3 loss links chromatin reorganization to metabolic vulnerability in glioma

B Brittney Lozzi (Program in Genetics and Genomics, Baylor College of Medicine) T Taylor A. Gatesman (Department of Neurological Surgery, University of Pittsburgh) P Pushan Dasgupta (Department of Neurology, Baylor College of Medicine) D Debosmita Sardar Y Yeunjung Ko (Center for Cell and Gene Therapy, Baylor College of Medicine) C Chenyu Mao (Center for Cell and Gene Therapy, Baylor College of Medicine) H Hsiao-Chi Chen R Rachel N. Curry (Center for Cell and Gene Therapy, Baylor College of Medicine) D Dongjoo Choi (Center for Cell and Gene Therapy, Baylor College of Medicine) C Carrie A. Mohila (Department of Pathology, Texas Children’s Hospital) M Melissa L. Bondy (Department of Epidemiology and Population Science, Stanford University) G Ganesh Rao (Department of Neurosurgery, Baylor College of Medicine) M Marco Gallo S Sameer Agnihotri B Benjamin Deneen

Abstract

High-grade gliomas (HGGs) are aggressive brain tumors with poor prognosis, driven in part by metabolic and epigenetic adaptations. Methionine metabolism supports HGG growth by supplying S-adenosylmethionine for methylation reactions, yet how nutrient availability influences chromatin organization in HGG remains incompletely understood. Using an immunocompetent mouse model of HGG, we found that dietary methionine restriction reduced tumor proliferation, extended survival, and induced partial nuclear inversion. We identified Hp1bp3 as a key regulator of tumor growth that functions by interacting with nuclear tethering proteins to mediate chromatin reorganization. Loss of Hp1bp3 results in the upregulation of histone demethylases leading to selective depletion of H3K9me3-marked heterochromatin and accelerated glioma growth. Combining methionine restriction with Hp1bp3 loss increased the frequency of partial nuclear inversion and further suppressed tumor progression. These findings identify Hp1bp3 as a chromatin regulator linking methionine metabolism to heterochromatin stability and suggest that dietary methionine modulation can influence the structural organization of chromatin to slow tumor growth in HGG.

Article Details

Volume / Issue Vol. 123, Issue 24
Published June 16, 2026
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (15)

B

Brittney Lozzi

Program in Genetics and Genomics, Baylor College of Medicine

T

Taylor A. Gatesman

Department of Neurological Surgery, University of Pittsburgh

P

Pushan Dasgupta

Department of Neurology, Baylor College of Medicine

D

Debosmita Sardar

Y

Yeunjung Ko

Center for Cell and Gene Therapy, Baylor College of Medicine

C

Chenyu Mao

Center for Cell and Gene Therapy, Baylor College of Medicine

H

Hsiao-Chi Chen

R

Rachel N. Curry

Center for Cell and Gene Therapy, Baylor College of Medicine

D

Dongjoo Choi

Center for Cell and Gene Therapy, Baylor College of Medicine

C

Carrie A. Mohila

Department of Pathology, Texas Children’s Hospital

M

Melissa L. Bondy

Department of Epidemiology and Population Science, Stanford University

G

Ganesh Rao

Department of Neurosurgery, Baylor College of Medicine

M

Marco Gallo

S

Sameer Agnihotri

B

Benjamin Deneen